Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 79 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 8067563

    Tumor suppressor gene, p471NG3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  2. US 8067202

    Bacterial superantigen vaccines

    The United States of America as represented by the Secretary of the Army · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  3. US 8063195

    Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  4. US 8063209

    Phosphonyl ester conjugates as prodrugs

    The United States of America as represented by the Department of Health and Human Services (DHHS) · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  5. US 8058248

    Foot and mouth disease virus vaccine comprising interferons

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  6. US 8058249

    Immunostimulatory nucleic acid molecules

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  7. US 8053443

    N-substituted indenoisoquinolines and syntheses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  8. US 8053422

    Anti-cancer oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  9. US 8048427

    Subgenomic replicons of the flavivirus dengue

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  10. US 8048432

    Polysaccharide-protein conjugate vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted

  11. US 8043622

    Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  12. US 8043623

    Immunogenic peptides for the treatment of prostate and breast cancer

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  13. US 8044057

    Methods for suppressing an immune response or treating a proliferative disorder

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  14. US 8044185

    Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  15. US 8044187

    Human luteinizing hormone superagonists

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  16. US 8044189

    Bacillus anthracis protective antigen nucleic acid sequences

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 25, 2011 · Expires Oct 20, 2031

    granted

  17. US 8038997

    Anti-marinobufagenin antibodies and methods for their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  18. US 8039003

    Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  19. US 8039593

    Antibodies and immunotoxins that target human glycoprotein NMB

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  20. US 8039585

    Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  21. US 8034334

    Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  22. US 8029809

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  23. US 8030285

    Oligodeoxynucleotide and its use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  24. US 8030287

    DNA vaccine against North American spring viremia of carp virus

    The United States of America as represented by the Secretary of the Army · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.